Hrishikesh Sharad Ponkshe
About Hrishikesh Sharad Ponkshe
Data last updated:
Hrishikesh Sharad Ponkshe has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 9 companies, including Serum Institute Vaccines Private Limited and Vakzine Pharma Private Limited. Formerly with 2 companies, such as Curohealth Bio-Pharma Llp and Phinity Developers Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 7 current companies with reported revenue have a combined latest revenue of ₹4,404 Cr; the largest is Rising Sun Holdings Pvt Ltd at ₹4,403 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rising Sun Holdings Pvt Ltd U67110PN1993PTC070989 | Director | 22 Dec 2018 | 1993 | ₹4,403 Cr (FY 2025) | Active |
 Serum Institute Vaccines Private Limited U24100PN2021PTC200477 | Director | 21 Apr 2021 | 2021 | ₹44.8 Lakh (FY 2025) | Active |
| Nishkruti Bio-Pharma Private Limited U24304TN2017PTC120869 | Director | 31 Jul 2017 | 2017 | ₹9.1 Lakh (FY 2025) | Active |
| Jivkalpa Pharma Private Limited U24304TN2017PTC121080 | Director | 15 Apr 2019 | 2017 | ₹1.9 Lakh (FY 2025) | Active |
| Vakzine Pharma Private Limited U24304TN2017PTC120889 | Director | 31 Jul 2017 | 2017 | ₹86,400 (FY 2025) | Active |
| Synergist Realtors Private Limited U45203PN2021PTC200464 | Director | 20 Apr 2021 | 2021 | ₹83,240 (FY 2025) | Active |
| Poonawalla Art Gallery Private Limited U92100PN2018PTC178405 | Director | 15 Apr 2019 | 2018 | ₹68,580 (FY 2025) | Active |
| Pravardhan Ventures Llp ACT-7588 | Designated Partner | 24 Dec 2025 | 2025 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Curohealth Bio-Pharma Llp AAZ-4213 | Designated Partner | 10 Nov 2021 | 2021 | – | Active |
| Phinity Developers Private Limited U70100PN2017PTC171794 | Director | 02 Aug 2017 | 2017 | ₹74.39 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hrishikesh Sharad Ponkshe
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hrishikesh Sharad Ponkshe
Hrishikesh Sharad Ponkshe has 9 years in corporate governance. Holds Director and Designated Partner roles. Currently with 9 companies, including Serum Institute Vaccines Private Limited and Vakzine Pharma Private Limited. Formerly with 2 companies, such as Curohealth Bio-Pharma Llp and Phinity Developers Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 7 current companies with reported revenue have a combined latest revenue of ₹4,404 Cr; the largest is Rising Sun Holdings Pvt Ltd at ₹4,403 Cr (FY 2025).
Hrishikesh Sharad Ponkshe is associated with 9 companies as Director and Designated Partner, including Rising Sun Holdings Pvt Ltd (₹4,403 Cr), Serum Institute Vaccines Private Limited (₹44.8 Lakh), Nishkruti Bio-Pharma Private Limited (₹9.1 Lakh).
Hrishikesh Sharad Ponkshe has expertise in General Business, Healthcare.
Hrishikesh Sharad Ponkshe has 9 years in corporate governance.
By reported revenue, the largest current company of Hrishikesh Sharad Ponkshe is Rising Sun Holdings Pvt Ltd, with revenue of ₹4,403 Cr (FY 2025).
The 7 current companies of Hrishikesh Sharad Ponkshe that report revenue have a combined latest revenue of ₹4,404 Cr.
Hrishikesh Sharad Ponkshe currently holds positions at 9 companies; the 5 largest by reported revenue are Rising Sun Holdings Pvt Ltd (₹4,403 Cr), Serum Institute Vaccines Private Limited (₹44.8 Lakh), Nishkruti Bio-Pharma Private Limited (₹9.1 Lakh), Jivkalpa Pharma Private Limited (₹1.9 Lakh), Vakzine Pharma Private Limited (₹86,400).